Maria Horga
Chief Tech/Sci/R&D Officer at ATEA PHARMACEUTICALS, INC.
Net worth: 103 683 $ as of 2024-03-30
Profile
Presently, Maria Arantxa Horga occupies the position of Chief Medical Officer for Atea Pharmaceuticals, Inc. In her past career she occupied the position of Group Director-Global Clinical Research at Bristol Myers Squibb Co., Vice President & Global Head-Clinical Program at Roche Innovation Center, Vice President-Pharmacovigilance at Biohaven Pharmaceuticals, Inc. and Head-Translational Medicine at F. Hoffmann-La Roche Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-31 | 25,664 ( 0.03% ) | 103 683 $ | 2024-03-30 |
Maria Horga active positions
| Companies | Position | Start |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2020-09-30 |
Former positions of Maria Horga
| Companies | Position | End |
|---|---|---|
Biohaven Pharmaceuticals, Inc.
 Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 2020-07-31 |
| Roche Innovation Center | Corporate Officer/Principal | 2019-07-31 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 2015-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Training of Maria Horga
| University of Santander | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Commercial Services |
| Roche Innovation Center |
- Stock Market
- Insiders
- Maria Horga
